The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Together, those 25 drugs account for a third of Medicare spending on prescriptions, Becerra said. Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

A major analysis of more than 1.2 million medical records has found popular diabetes and weight loss drugs, including Ozempic and Wegovy, may also reduce the risk of other health issues.

Credit: Novo Nordisk. The approval was based on data from the randomized, double-blind, placebo-controlled FLOW trial. Semaglutide reduced the risk of kidney disease worsening, renal failure, and ...

Bloomberg/Getty Images One big area of concern for users of GLP-1 medications such as Ozempic and Wegovy is preventing ... they found that muscle cells contain high levels of a protein called ...

One big area of concern for users of GLP-1 medications such as Ozempic and Wegovy is preventing ... they found that muscle cells contain high levels of a protein called BCL6, suggesting it may ...

Ozempic and other semaglutide injections such as Wegovy have been in short supply for years due to their rapid popularity. The FDA now lists Ozempic as “available,” but there is still high demand.

high-fat foods, and refined carbohydrates. This Is How Ozempic Interacts With Birth Control 6 Foods To Avoid While On Ozempic How Ozempic Could Lower Dementia Risk Another thing to keep in mind ...